TD Asset Management
GEVA

TD Asset Management’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

TD Asset Management’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-25,300
Closed -$2.47M – 1448
2015
Q1 		$2.47M Buy
25,300
+14,600
+136% +$1.42M ﹤0.01% 803
2014
Q4 		$993K Buy
+10,700
New +$993K ﹤0.01% 935